Table 1.
Group | n | Experiment 1 | Experiment 2 | ||
---|---|---|---|---|---|
Acquisition (Sessions 1–23) | Drug Pretreatment (Sessions 24–30) | nAChR (Sessions 31–35) | NE-R (Sessions 41–52) | ||
SAL | 8 | Active Lever: VS (FR1, FR2, FR5) | SAL (IP/SC) | 0, 0.05, 0.1 mg/kg mecamylamine | 0, 0.1, 0.3, 1 mg/kg prazosin |
0.4 NIC | 8 | 0.4 NIC | |||
3 BUP | 9 | 3 BUP | 0, 2.5, 5, 10 mg/kg propranolol | ||
10 BUP | 9 | 10 BUP | |||
30 BUP | 8 | 30 BUP |